References
- YueDKSwansonBMcLennanSMarshMAbnormalities of granulation tissue and collagen formation in experimental diabetesDiab Med19863221225
- BitarMSZiadNLabbadNTransforming growth factor beta and insulin-like growth factor-1 in relation to diabetes-induced impairment of wound healingJ Surg Res1996611131198769952
- WaughHVSherrattJAMacrophage dynamics in diabetic wound dealingBull Math Biol20066819720716794927
- LiuRBalHSDestaTBehlYGravesDTTumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healingAm J Pathol200616875776416507891
- O’ConnorJCJohnsonDRFreundGGPsychoneuroimmune implications of type 2 diabetesNeurol Clin20062453955916877123
- GorenIKampferHPoddaMPfeilschifterJFrankSLeptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediatorsDiabetes2003522821283214578302
- PintoFAMalucelliBEInflammatory infiltrate, VEGF, and FGF-2 contents during corneal angiogenesis in STZ-diabetic ratsAngiogenesis20025677412549861
- GorenIMullerEPfeilschifterJFrankSSeverely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alphaAm J Pathol20066876577716507892
- FaheyTJSadatyAJonesWGBarberASmollerBShiresGTDiabetes impairs the late inflammatory response to wound healingJ Surg Res1991503083132020184
- NormanMUHickeyMJMechanisms of lymphocyte migration in autoimmune diseaseTissue Antigens20056616317216101827
- American Diabetes AssociationDiabetes 2002 Vital StatisticsAlexandria, VAAmerican Diabetes Association2002
- HinchliffeRJValkGDApelqvistJA systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetesDiabetes Metab Res Rev2008S11914418442185
- MatosTJDuarteCBGoncaloMLopesMCDNFB activates MAPKs and upregulates CD40 in skin-derived dendritic cellsJ Dermatol Sci20053911312315896946
- HildesheimJAwwadRTFornaceAJ Jrp38 mitogen-activated protein kinase inhibitor protects the epidermis against the acute damaging effects of ultraviolet irradiation by blocking apoptosis and inflammatory responsesJ Invest Dermatol200412249750215009736
- MedicherlaSProtterAAMaJYPreventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetesJ Pharmacol Exp Ther20063189910716603672
- MedicherlaSMaJYMangaduRA selective p38 alpha mitogen activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen induced arthritisJ Pharmacol Exptl Ther200631813214116597712
- NguyenANStebbinsEGHensonMNormalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppress osteoclast formationExp Cell Res20063121909192316600214
- NavasTAMohindruMEstesMInhibition of over activated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitorsBlood20061084170417716940419
- OhuraNKuritaTTakushimaAShibataMHariiKEfficacy of skin-protection powder for use as a dressing intractable ulcersJ Wound Care20061547147617124823
- ToyamaTOhuraNKuritaMMomosawaAHarriKEffectiveness of short-contact topical tretinoin in promoting wound healing in db/db miceScand J Plast Reconstr Surg Hand Surg20064032933417118897
- HartJSilcockDGunnigleSCullenBLightNDWattPWThe role of oxidized regenerated cellulose/collagen in wound repair: effects in vitro on fibroblast biology and in vivo in a model of compromised healingInt J Biochem Cell Biol2002341557157012379278
- LobmannRZemlinCMotzkauMReschkeKLehnertHExpression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressingJ Diabetes Complications20062032933516949521
- KumarSMcDonnellPCGumRJHandATNovel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazolesBiochem Biophys Res Commun19972355335389207191
- StvenssonCIMedicherlaSMalkmusSSpinal and DRG p38 MAP kinase in osteosarcoma pain modelPharmacol Biochem Behav20089066467518584857
- VanderkerkenKMedicherlaSCoultonLProtterAAHigginsLSCroucherPIInhibition of p38 MAPK prevents the development of myeloma bone disease, reduces tumor burden and increases survival in murine models of myelomaCancer Res2007674572457717495322
- DobrevaIWaeberGJamesRWWidmannCInterleukin-8 secretion by fibroblasts induced by low density lipoproteins is p38 MAPK dependent and leads to cells spreading and wound closureJ Biol Chem200628119920516251188
- AlikhaniMMaclellanCRaptisMVoraSTrackmanPGravesDAdvanced glycation end products induced apoptosis in fibroblasts through activation of ROS, MAP kinases and FOXO1 transcription factorAm J Physiol Cell Physiol2007292C85085617005604
- CollinsQFXiongYLupoEGLiuHYCaoWp38 mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytesJ Biol Chem2006281243362434416803882
- MansfiedPJHinkovska-GalchevaVCareySSShaymanJABoxerLARegulation of polymorphonuclear leukocyte degranulation and oxidant production by ceramide through inhibition of phospholipase DBlood2002991434144111830497
- HiranoSReesRSGilmontRRMAP kinase pathways involving hsp27 regulates fibroblast–mediated wound contractionJ Surg Res2002102778411796002
- YavuzDTugtepeHCetinelSCollagen ultra structure and TGF beta1 expression preserved with aminoguanidine during wound healing in diabetic ratsEndocr Res20053122924316392625